| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |